The global biotech market is expected to reach roughly $6 trillion in the next decade. Opportunities like that leave our subscribers salivating, so they've asked us to help them find the best way to invest in this nascent industry. Today, we'll explore the top two biotech ETFs: XBI and IBB. It was tough to pick a winner, but one came out slightly ahead for reasons you'll see in this piece.

Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/w09d9ooPGkM.